LPGO_BTA fundamentals
An in-depth look to LIPIGON PHARMACEUTICALS AB BTA operating, investing, and financing activities
LPGO_BTA free cash flow for Q1 25 is -9.71 M SEK. For 2024, LPGO_BTA free cash flow was -25.02 M SEK and operating cash flow was -24.78 M SEK.
Q3 '19
Q2 '20
Q3 '20
Q4 '20
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: SEK
Q3 '19
Q2 '20
Q3 '20
Q4 '20
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
TTM